BioMarker Strategies, a local start-up, has decided to locate its headquarters at 855 N. Wolfe St., adjacent to the Johns Hopkins Medical Institutions' campus after touring the other facilities in the area. "The market has become very competitive," Scott Allocco, president of BioMarker Strategies tells GlobeSt.com. Other tenants that have inked leases at the park include the Johns Hopkins Institute for Basic Biomedical Sciences, the Howard Hughes Medical Institute and Cangen Biotechnologies.

The Science + Technology Park at Johns Hopkins is being developed by the Forest City-New East Baltimore Partnership as part of a larger mixed-use development program. Development plans for the 31-acre, phase one area includes the 1.1-million-sf Science + Technology Park, more than 850 housing units for mixed-income buyers and renters, and retail services.

Maryland, of course, has been building out its biotech bona fides for several years, with the 270-Corridor now renown throughout the country for its facilities. Increasingly real estate firms are following suit, developing specialty practices for this space. Cushman & Wakefield, to cite one example, is working to expand its footprint in the local life science market and other Mid-Atlantic cities.